Precision Oncology Platform

Celebal Technologies' Precision Oncology Platform is a comprehensive digital healthcare solution aimed at customizing treatments for individual patients while supporting data-driven research in precision oncology. This genomic platform facilitates secondary and tertiary analysis of the genome or exome, providing researchers and clinicians with deeper insights. Through an interactive visualization dashboard, it streamlines the testing process by converting next-generation sequencing data into meaningful clinical information and strategic insights.  

Addressing challenges in genome sequencing and analysis, the platform leverages advanced technologies like Microsoft Azure, Microsoft Genomics Resource, and Azure Databricks. This all-in-one solution enables in-depth gene mutation analysis in cancer cells, facilitating personalized treatment strategies and molecular tumor profiling to identify targetable alterations. Additionally, it supports research and development, diagnostics, prognosis, detailed variant analysis, biomarker identification, drug efficacy assessment, and side-effect evaluation. By combining advanced computing with genetic insights, the platform enhances precision oncology applications, offering a streamlined and efficient solution for medical professionals and researchers. 

Key Highlights:  

• Customizable Analysis Tool: Tailored for clinical and research use, offering end-to-end genomics analysis (Secondary + Tertiary). 

• Accelerated Secondary Analysis: Uses Microsoft Genomics and Cromwell, adhering to GATK (Genome Analysis Toolkit) best practices. 

• Data Security: Ensured by Microsoft Azure’s data security protocols. 

• In-house Analysis Tools: MSI (Microsatellite Instability) and TMB (Tumor Mutational Burden) analysis tools for score and status prediction. 

• Integrated Resources: Combines multiple biological databases and bioinformatics tools for comprehensive clinical interpretation. 

• Detailed Reporting: Provides a primary report with a variant analysis summary and an interactive dashboard for in-depth analysis. 

• Notification Alerts: Sends email alerts to authorized users upon sample processing completion. 

• Wide Applications: Useful for cancer treatment guidance, biomarker identification, oncology R&D, genomic analysis, gene manipulation, and drug discovery. 

• Efficient Turnaround Time: Processes the entire human genome in 10 hours (standard setting) and completes tertiary analysis in 15-20 minutes. DRAGEN mode accelerates secondary analysis to ~1 hour (additional licenses required). 

Seamless genomic analysis is within reach—see how we can help!